Retail Promised Fair Markets, Yet the House Keeps Winning
Retail investors surged into crypto trading as access expanded, but the market remains tilted toward institutions and...
What To Consider When Choosing Rewards
Choosing the right rewards requires understanding several factors. This guide highlights what you should consider for optimal benefits.
17,409 articles
Oil Near $100 Barrel, Here’s the ETF Investors Should Buy
Oil trades around the $100 barrel mark as investors seek safety. This piece identifies a top defensive ETF and explai...
Melius Analyst Flags Red Flag Over Copilot Reshuffle
A Melius analyst warns that Microsoft's Copilot leadership reshuffle may signal deeper misalignment between AI ambiti...
Cursor's Rise, Uncertain Future in AI Coding Boom Era Unfolding
Cursor, valued near $29 billion, stands at the center of a fast-moving AI coding boom. The company faces intense grow...
What OpenAI’s Risk Disclosure Signals Microsoft’s Position
OpenAI’s IPO-style risk disclosure confirms Microsoft’s central role in its operations, signaling potential leverage ...
Europe Survived Energy Shocks, Now Plans Homegrown Power
Europe endures a third energy shock in four years, pressuring households and small businesses to rework budgets and s...
Surgeons, Airline Pilots, Software Drive Female Hires
Women are breaking into top-paying, traditionally male-dominated fields. In 2026, surgeons, airline pilots, and softw...
With Stock Down Roughly 60%: Should Nike Be a Buy?
Nike has faced a decades-long love-hate relationship with investors: the brand remains powerful, but the stock has sl...
Cardano Just Caught Major Break: Is It a Buy Now Today?
Cardano just caught major regulatory clarity, a development that could reduce some risk for investors. This guide bre...
Bond Billion Investors Trust Faces Five-Year Return Lag
The iShares Core U.S. Aggregate Bond ETF (AGG) has produced a five-year price return near zero, even as it manages mo...
SpaceX Allocate Retail Investors Could Redefine IPOs
If SpaceX shifts a sizable slice of its IPO to everyday investors, the market could see bigger demand and new pricing...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status